Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing YYD601 for erosive esophagitis has completed; results not detailed in provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• YYD601

Snippet

Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Erosive Esophagitis | Phase 3 | Status: COMPLETED